These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 34473249)

  • 1. Anticoagulation, therapy of concomitant conditions, and early rhythm control therapy: a detailed analysis of treatment patterns in the EAST - AFNET 4 trial.
    Metzner A; Suling A; Brandes A; Breithardt G; Camm AJ; Crijns HJGM; Eckardt L; Elvan A; Goette A; Haegeli LM; Heidbuchel H; Kautzner J; Kuck KH; Mont L; Ng GA; Szumowski L; Themistoclakis S; van Gelder IC; Vardas P; Wegscheider K; Willems S; Kirchhof P
    Europace; 2022 Apr; 24(4):552-564. PubMed ID: 34473249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic, early rhythm control strategy for atrial fibrillation in patients with or without symptoms: the EAST-AFNET 4 trial.
    Willems S; Borof K; Brandes A; Breithardt G; Camm AJ; Crijns HJGM; Eckardt L; Gessler N; Goette A; Haegeli LM; Heidbuchel H; Kautzner J; Ng GA; Schnabel RB; Suling A; Szumowski L; Themistoclakis S; Vardas P; van Gelder IC; Wegscheider K; Kirchhof P
    Eur Heart J; 2022 Mar; 43(12):1219-1230. PubMed ID: 34447995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving outcomes in patients with atrial fibrillation: rationale and design of the Early treatment of Atrial fibrillation for Stroke prevention Trial.
    Kirchhof P; Breithardt G; Camm AJ; Crijns HJ; Kuck KH; Vardas P; Wegscheider K
    Am Heart J; 2013 Sep; 166(3):442-8. PubMed ID: 24016492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generalizability of the EAST-AFNET 4 Trial: Assessing Outcomes of Early Rhythm-Control Therapy in Patients With Atrial Fibrillation.
    Dickow J; Kirchhof P; Van Houten HK; Sangaralingham LR; Dinshaw LHW; Friedman PA; Packer DL; Noseworthy PA; Yao X
    J Am Heart Assoc; 2022 Jun; 11(11):e024214. PubMed ID: 35621202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rationale and design of AXAFA-AFNET 5: an investigator-initiated, randomized, open, blinded outcome assessment, multi-centre trial to comparing continuous apixaban to vitamin K antagonists in patients undergoing atrial fibrillation catheter ablation.
    Di Biase L; Callans D; Hæusler KG; Hindricks G; Al-Khalidi H; Mont L; Cosedis Nielsen J; Piccini JP; Schotten U; Kirchhof P
    Europace; 2017 Jan; 19(1):132-138. PubMed ID: 28130378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eligibility for early rhythm control in patients with atrial fibrillation in the UK Biobank.
    Kany S; Cardoso VR; Bravo L; Williams JA; Schnabel R; Fabritz L; Gkoutos GV; Kirchhof P
    Heart; 2022 Nov; 108(23):1873-1880. PubMed ID: 35835543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Update atrial fibrillation: the 2020 ESC guidelines and recent data on early rhythm control].
    Schleberger R; Rillig A; Kirchhof P; Metzner A; Reissmann B
    Herzschrittmacherther Elektrophysiol; 2021 Jun; 32(2):257-263. PubMed ID: 33783622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early rhythm-control therapy for atrial fibrillation in patients with a history of stroke: a subgroup analysis of the EAST-AFNET 4 trial.
    Jensen M; Suling A; Metzner A; Schnabel RB; Borof K; Goette A; Haeusler KG; Zapf A; Wegscheider K; Fabritz L; Diener HC; Thomalla G; Kirchhof P
    Lancet Neurol; 2023 Jan; 22(1):45-54. PubMed ID: 36517170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early Rhythm-Control Therapy in Patients with Atrial Fibrillation.
    Kirchhof P; Camm AJ; Goette A; Brandes A; Eckardt L; Elvan A; Fetsch T; van Gelder IC; Haase D; Haegeli LM; Hamann F; Heidbüchel H; Hindricks G; Kautzner J; Kuck KH; Mont L; Ng GA; Rekosz J; Schoen N; Schotten U; Suling A; Taggeselle J; Themistoclakis S; Vettorazzi E; Vardas P; Wegscheider K; Willems S; Crijns HJGM; Breithardt G;
    N Engl J Med; 2020 Oct; 383(14):1305-1316. PubMed ID: 32865375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mortality benefit with AF ablation: Impact of normal sinus rhythm seen in CABANA and EAST AFnet.
    Crawford M; Steinberg BA; Ranjan R; Konstantinidis K; Navaravong L; Bunch TJ
    J Cardiovasc Electrophysiol; 2024 Mar; 35(3):538-546. PubMed ID: 38131368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rate versus rhythm control for atrial fibrillation: from AFFIRM to EAST-AFNET 4 - a paradigm shift.
    Roman S; Patel K; Hana D; Guice KC; Patel J; Stadnick C; Basta A; Khouzam RN
    Future Cardiol; 2022 Apr; 18(4):354-353. PubMed ID: 35255732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attaining sinus rhythm mediates improved outcome with early rhythm control therapy of atrial fibrillation: the EAST-AFNET 4 trial.
    Eckardt L; Sehner S; Suling A; Borof K; Breithardt G; Crijns H; Goette A; Wegscheider K; Zapf A; Camm J; Metzner A; Kirchhof P
    Eur Heart J; 2022 Oct; 43(40):4127-4144. PubMed ID: 36036648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The 2020 ESC atrial fibrillation guidelines for atrial fibrillation catheter ablation, CABANA, and EAST.
    Arbelo E; Dagres N
    Europace; 2022 Jun; 24(Suppl 2):ii3-ii7. PubMed ID: 35661865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longer and better lives for patients with atrial fibrillation: the 9th AFNET/EHRA consensus conference.
    Linz D; Andrade JG; Arbelo E; Boriani G; Breithardt G; Camm AJ; Caso V; Nielsen JC; De Melis M; De Potter T; Dichtl W; Diederichsen SZ; Dobrev D; Doll N; Duncker D; Dworatzek E; Eckardt L; Eisert C; Fabritz L; Farkowski M; Filgueiras-Rama D; Goette A; Guasch E; Hack G; Hatem S; Haeusler KG; Healey JS; Heidbuechel H; Hijazi Z; Hofmeister LH; Hove-Madsen L; Huebner T; Kääb S; Kotecha D; Malaczynska-Rajpold K; Merino JL; Metzner A; Mont L; Ng GA; Oeff M; Parwani AS; Puererfellner H; Ravens U; Rienstra M; Sanders P; Scherr D; Schnabel R; Schotten U; Sohns C; Steinbeck G; Steven D; Toennis T; Tzeis S; van Gelder IC; van Leerdam RH; Vernooy K; Wadhwa M; Wakili R; Willems S; Witt H; Zeemering S; Kirchhof P
    Europace; 2024 Mar; 26(4):. PubMed ID: 38591838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early Rhythm Control and the Risks of Ischemic Stroke, Heart Failure, Mortality, and Adverse Events When Performed Early (<3 Months): A Nationwide Cohort Study of Newly Diagnosed Patients with Atrial Fibrillation.
    Chao TF; Chan YH; Chiang CE; Tuan TC; Liao JN; Chen TJ; Lip GYH; Chen SA
    Thromb Haemost; 2022 Nov; 122(11):1899-1910. PubMed ID: 35322396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Real-world applicability and impact of early rhythm control for European patients with atrial fibrillation: a report from the ESC-EHRA EORP-AF Long-Term General Registry.
    Proietti M; Vitolo M; Harrison SL; Lane DA; Fauchier L; Marin F; Nabauer M; Potpara TS; Dan GA; Boriani G; Lip GYH;
    Clin Res Cardiol; 2022 Jan; 111(1):70-84. PubMed ID: 34448931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early and comprehensive management of atrial fibrillation: executive summary of the proceedings from the 2nd AFNET-EHRA consensus conference 'research perspectives in AF'.
    Kirchhof P; Bax J; Blomstrom-Lundquist C; Calkins H; Camm AJ; Cappato R; Cosio F; Crijns H; Diener HC; Goette A; Israel CW; Kuck KH; Lip GY; Nattel S; Page RL; Ravens U; Schotten U; Steinbeck G; Vardas P; Waldo A; Wegscheider K; Willems S; Breithardt G
    Eur Heart J; 2009 Dec; 30(24):2969-77c. PubMed ID: 19535417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early Rhythm Control Therapy for Atrial Fibrillation in Low-Risk Patients : A Nationwide Propensity Score-Weighted Study.
    Kim D; Yang PS; You SC; Jang E; Yu HT; Kim TH; Pak HN; Lee MH; Lip GYH; Sung JH; Joung B
    Ann Intern Med; 2022 Oct; 175(10):1356-1365. PubMed ID: 36063552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benefits of early rhythm control of atrial fibrillation.
    Eckardt L; Wolfes J; Frommeyer G
    Trends Cardiovasc Med; 2024 Jul; 34(5):288-294. PubMed ID: 37054762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early Rhythm Control Therapy in Patients With Atrial Fibrillation and Heart Failure.
    Rillig A; Magnussen C; Ozga AK; Suling A; Brandes A; Breithardt G; Camm AJ; Crijns HJGM; Eckardt L; Elvan A; Goette A; Gulizia M; Haegeli L; Heidbuchel H; Kuck KH; Ng A; Szumowski L; van Gelder I; Wegscheider K; Kirchhof P
    Circulation; 2021 Sep; 144(11):845-858. PubMed ID: 34328366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.